MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, Invizyne Technologies, Inc. (Invizyne). The Company's segments include broker dealer & intellectual property service, and technology development.
The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence.
The technology development segment has one subsidiary, Invizyne. Invizyne is a research and development stage synthetic biology company. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations..
Price and Volume | |
---|---|
Volume | |
Ten Day Average Volume | 8.4K |
Three Month Average Volume | 254.9K |
High Low | |
Fifty-Two Week High | 21.67 USD |
Fifty-Two Week Low | 7.0001 USD |
Fifty-Two Week High Date | 21 Sep 2023 |
Fifty-Two Week Low Date | 27 Jun 2024 |
Price and Volume | |
Current Price | 8.095 USD |
Beta | -100,000 |
Relative Price Change | |
Four Week Relative Price Change | -26.11% |
Thirteen Week Relative Price Change | -12.05% |
Twenty-Six Week Relative Price Change | -35.98% |
Fifty-Two Week Relative Price Change | -99,999.99% |
Year-to-Date Relative Price Change | -40.74% |
Price Change | |
One Day Price Change | -2.12% |
Thirteen Week Price Change | -5.87% |
Twenty-Six Week Price Change | -29.61% |
Five Day Price Change | -1.36% |
Fifty-Two Week Price Change | -99,999.99% |
Year-to-Date Price Change | -29.82% |
Month-to-Date Price Change | -17.06% |
Per Share Data | |
---|---|
Book Value | |
Book Value Per Share (Last Fiscal Year) | 4.01402 USD |
Book Value Per Share (Most Recent Quarter) | 3.54821 USD |
Tangible Book Value Per Share (Last Fiscal Year) | 4.01402 USD |
Tangible Book Value Per Share (Most Recent Quarter) | 3.54821 USD |
EBITD | |
EBITD Per Share (Trailing Twelve Months) | -2.53683 USD |
Revenue | |
Revenue Per Share (Last Fiscal Year) | 0.74637 USD |
Revenue Per Share (Trailing Twelve Months) | 0.20451 USD |
Dividend | |
Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
Dividend Per Share (Trailing Twelve Months) | 0 USD |
Dividend Per Share (5 Year) | -99999.99 USD |
Earnings Per Share | |
Excluding Extraordinary Items (Last Fiscal Year) | -0.86042 USD |
Excluding Extraordinary Items (Trailing Twelve Months) | -2.21651 USD |
Normalized (Last Fiscal Year) | -0.85641 USD |
Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.86042 USD |
Basic Excluding Extraordinary Items (Trailing Twelve Months) | -2.21651 USD |
Including Extraordinary Items (Last Fiscal Year) | -0.86042 USD |
Including Extraordinary Items (Trailing Twelve Months) | -2.21651 USD |
Cash | |
Cash Per Share (Last Fiscal Year) | 0.79152 USD |
Cash Per Share (Most Recent Quarter) | 2.20552 USD |
Cash Flow Per Share (Last Fiscal Year) | -0.92783 USD |
Cash Flow Per Share (Trailing Twelve Months) | -2.38608 USD |
Free Cash Flow Per Share (Trailing Twelve Months) | -1.18144 USD |
Margins | |
---|---|
Cash Flow Revenue | |
Cash Flow Revenue (5 Year) | -100,000 |
Cash Flow Revenue (Trailing Twelve Months) | -578 |
Pretax Margin | |
Pretax Margin (Trailing Twelve Months) | -1,190.26% |
Pretax Margin (Last Fiscal Year) | -125.46% |
Pretax Margin (5 Year) | -99,999.99% |
Gross Margin | |
Gross Margin (Last Fiscal Year) | -99,999.99% |
Gross Margin (Trailing Twelve Months) | -99,999.99% |
Gross Margin (5 Year) | -99,999.99% |
Operating Margin | |
Operating Margin (Last Fiscal Year) | -140.66% |
Operating Margin (Trailing Twelve Months) | -1,256.28% |
Operating Margin (5 Year) | -99,999.99% |
Net Profit Margin | |
Net Profit Margin (Last Fiscal Year) | -127.57% |
Net Profit Margin (Trailing Twelve Months) | -1,179.83% |
Net Profit Margin (5 Year) | -99,999.99% |
Growth | |
---|---|
Book Value | |
Book Value Per Share (5 Year) | -99,999.99% |
Tangible Book Value (5 Year) | -99,999.99% |
Free Operating Cash Flow | |
Free Operating Cash Flow (5 Year) | -99,999.99% |
Revenue | |
Revenue Change MRQ vs 1 Year Ago | -60.06% |
Revenue Growth (3 Year) | -99,999.99% |
Revenue Change (Trailing Twelve Months) | -74.04% |
Revenue Per Share Growth | -99,999.99% |
Revenue Growth (5 Year) | 20.53% |
Capital Spending Debt | |
Capital Spending (5 Year) | -99,999.99% |
Total Debt (5 Year) | -99,999.99% |
Dividends | |
Dividend Growth (3 Year) | -99,999.99% |
Earnings Per Share | |
EPS Change MRQ vs 1 Year Ago | -201.30% |
EPS Change (Trailing Twelve Months) | -7,585.54% |
EPS Growth (3 Year) | -99,999.99% |
EPS Growth (5 Year) | -99,999.99% |
EBITDA | |
EBITDA (5 Year) | -99,999.99% |
EBITDA (5 Year Interim) | -99,999.99% |
Net Profit Margin | |
Net Profit Margin Growth (5 Year) | -99,999.99% |
Valuation | |
---|---|
Total Price to Book | |
Price to Tangible Book (Last Fiscal Year) | 2 |
Price to Tangible Book (Most Recent Quarter) | 2 |
Price to Free Cash Flow | |
Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
Net Debt | |
Net Debt (Most Recent Quarter) | -20,501,680 |
Net Debt (Last Fiscal Year) | -7,357,690 |
Price to Sales | |
Price to Sales (Last Fiscal Year) | 12 |
Price to Sales (Trailing Twelve Months) | 41 |
Price to Earnings | |
PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
PE Normalized (Last Fiscal Year) | -100,000 |
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
Dividends | |
Dividend Yield (5 Year) | -99,999.99% |
Dividend Yield | -99,999.99% |
Current Dividend Yield | 0.00% |
Price to Book | |
Price to Book (Last Fiscal Year) | 2 |
Price to Book (Most Recent Quarter) | 2 |
Financial Strength | |
---|---|
Debt to Equity | |
Long Term Debt to Equity (Last Fiscal Year) | 0 |
Long Term Debt to Equity (Most Recent Quarter) | 0 |
Payout Ratio | |
Payout Ratio (Last Fiscal Year) | -99,999.99% |
Payout Ratio (Trailing Twelve Months) | -99,999.99% |
Quick Ratio | |
Quick Ratio (Last Fiscal Year) | -100,000 |
Quick Ratio (Most Recent Quarter) | -100,000 |
Enterprise Value | |
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
Current Ratio | |
Current Ratio (Last Fiscal Year) | -100,000 |
Current Ratio (Most Recent Quarter) | -100,000 |
Free Cash Flow | |
Free Cash Flow (Last Fiscal Year) | -7,599,820 |
Free Cash Flow (Trailing Twelve Months) | -10,552,740 |
Net Interest Coverage | |
Net Interest Coverage (Last Fiscal Year) | -100,000 |
Net Interest Coverage (Trailing Twelve Months) | -100,000 |
Total Debt to Equity | |
Total Debt to Equity (Last Fiscal Year) | 0 |
Total Debt to Equity (Most Recent Quarter) | 0 |
Management Effectiveness | |
---|---|
Return on Assets | |
Return on Assets (Last Fiscal Year) | -22.45% |
Return on Assets (Trailing Twelve Months) | -66.19% |
Return on Assets (5 Year) | -99,999.99% |
Return on Equity | |
Return on Equity (Last Fiscal Year) | -23.25% |
Return on Equity (Trailing Twelve Months) | -70.08% |
Return on Equity (5 Year) | -99,999.99% |
Return on Investment | |
Return on Investment (Last Fiscal Year) | -25.57% |
Return on Investment (Trailing Twelve Months) | -74.67% |
Return on Investment (5 Year) | -99,999.99% |